Company Parnax Lab Limited

PARNAXLAB6

INE383L01019

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Biopharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:59 2024-06-21 EDT			5-day change	1st Jan Change
107.6 ^INR	-1.99%		-4.70%	+22.08%

05-30	Parnax Lab Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
05-30	Parnax Lab Limited Approves Reconstitution of Committees of Board of Directors	CI

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. It is also focused on the trading of pharmaceuticals and medicinal products. The Company operates through dealing in the pharmaceutical formulations segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, highly viscous products, suspensions and others. The Companyâs subsidiary is Naxpar Pharma Private Limited.

Number of employees: 12

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceuticals and Medicinal Products 100.0 %	1,630	100.0 %	1,676	100.0 %	+2.81%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	1,630	100.0 %	1,676	100.0 %	+2.81%

Managers	Title	Age	Since
Prakash Mansukhlal Shah CEO	Chief Executive Officer	80	10-12-06
Baiju Mansukhlal Shah DFI	Director of Finance/CFO	69	10-12-06
Preet Vijay Kukreja CMP	Compliance Officer	-	21-06-20

Members of the board	Title	Age	Since
Vinayak Babli Desai BRD	Director/Board Member	83	10-07-31
Prakash Mansukhlal Shah CEO	Chief Executive Officer	80	10-12-06
Baiju Mansukhlal Shah DFI	Director of Finance/CFO	69	10-12-06
Ami Mihir Shah BRD	Director/Board Member	47	15-03-30
Tirunillai V. Anantharaman BRD	Director/Board Member	-	15-03-30
Yogesh Kantilal Varia BRD	Director/Board Member	70	21-05-27
Harish S. Panpalia BRD	Director/Board Member	64	23-08-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,485,616	2,995,850 ( 26.08 %)	0	26.08 %

Parnax Lab Ltd.

Jogani Industrial Complex Building No. 8, Gala No. 114

400022, Mumbai

http://www.naxparlab.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
PARNAX LAB LIMITED	+22.08%	15.08M
CSL LIMITED	+2.22%	93.53B
SAMSUNG BIOLOGICS CO.,LTD.	-1.32%	38.27B
BIOGEN INC.	-13.44%	32.84B
UCB	+76.30%	27.83B
BIOMARIN PHARMACEUTICAL INC.	-13.11%	16.08B
INCYTE CORPORATION	+0.68%	14.02B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.06%	11.47B
ALTEOGEN INC.	+185.28%	9.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-53.00%	9.42B

Biopharmaceuticals